Therapeutic Guidelines

11/01/2026

✨ Migraine management made clearer!
📃 Discover the latest recommendations in treatment, including the evolving role of calcitonin gene-related peptide ( ) targeted therapies (both monoclonal antibodies and gepants). If initial prophylaxis falls short, these guidelines help you navigate the next steps with confidence. Keep your clinical decision-making headache-free.
💻 Explore what's new➡️ https://bit.ly/3KWDNmZ

17/12/2025

🧠 Thinking ahead – the Neurology guidelines have had a major update!
💡 Highlights include new flowcharts for management of seizures and drug management of status epilepticus, expanded neonatal guidance, revised management including calcitonin gene-related peptide ( ) therapies, updated stroke advice, refreshed restless legs syndrome recommendations, advice about new disease-modifying therapies for multiple sclerosis and new tools for the management of peripheral neuropathy.
🌟 What’s new?
New topics on functional disorders, perimenopausal migraine, migraine in transgender individuals, headache and reversible cerebral vasoconstriction syndrome.

📖 Explore now: https://bit.ly/3KWDNmZ

17/12/2025

🩺 New surgical prophylaxis guidelines released!
Surgical prophylaxis is the most common reason for antibiotic use in hospitals – but inappropriate prescribing remains high, especially around timing and duration.
Updated surgical prophylaxis guidance, including easy-to-follow printable summary tables are available now to support best practice.
Explore more: https://bit.ly/3L5o1WZ

Dr Paul Anderson, Urologist and member of the Antibiotic Guidelines expert group, outlines some of the updates to surgical antibiotic prophylaxis from the 20...

10/12/2025

Welcome to the next era of Therapeutic Guidelines! 🚀

Today, Therapeutic Guidelines launched a new desktop app experience with elevated designs, enhanced search features, modern layouts and intuitive navigation to streamline clinical workflows and positively impact patient care outcomes.

So, what new features and improvements can you expect?
✔ Streamlined user-friendly navigation for quick access to guidelines, calculators, favourites, and resources.
✔ Improved predictive search and a new ‘filter by guideline’ option for faster results.
✔ Elevated user-centric design and category pages for the 21 guidelines, with links to relevant topics, updates, tables and figures.

The new era awaits 👉 https://bit.ly/4rEp54L

28/11/2025

Did you hear yesterday's news that ObesiD is coming? ObesiD is an innovative dosing in obesity resource brought to you by Advanced Pharmacy Australia (AdPha) and powered by Therapeutic Guidelines. 🤝💜

Register your interest (https://bit.ly/4pzrWKa) or pop by booth number 57 at to hear more about it!

27/11/2025

Big news from the Medicines Management conference this morning! Therapeutic Guidelines and Advanced Pharmacy Australia (AdPha) are now partners!

The partnership will deliver ObesiD, a brand-new clinical resource developed by AdPha and powered by Therapeutic Guidelines' technology platform. The new resource will provide easy access to concise guidance on the principles of dosing in patients with obesity, calculators, and evidence-based dosing advice for more than 70 medicines. ObesiD will be available on desktop and mobile apps from March 2026.

Register your interest to be among the first to get access: https://bit.ly/4pzrWKa

19/11/2025

The theme of World AMR Awareness Week 2025 is Act Now: Protect Our Present, Secure Our Future.

Did you know? Antimicrobial resistance (AMR) happens when bacteria, fungi, viruses, or parasites can withstand the effects of antimicrobial drugs. That means infections become harder, and sometimes impossible, to treat.

Why does this matter? If we don’t act now, the medicines we rely on today might not work tomorrow.

To learn more, see the Antibiotic Guidelines: https://bit.ly/4o5wTcD

12/11/2025

Diagnosing pneumonia in a patient recently discharged from hospital? You might need to treat them for hospital-acquired pneumonia.

The definition of hospital-acquired pneumonia now includes:
🏥 patients hospitalised in acute care for longer than 48 hours
AND
🏡 patients discharged within the last 7 days (if they were in acute care for longer than 48 hours)

Stay sharp, stay updated! Check out the updates to the Antibiotic guidelines: https://bit.ly/4hVNMDt

05/11/2025

Did you know behavioural and symptoms of are often temporary and can usually be prevented and treated with nonpharmacological management?

Based on patient assessment, create an individualised behavioural management plan considering the patient’s preferences and goals of care. If the patient is unable to participate in the planning, review their advance care management plan and consult with their substitute decision-maker.

Get more info in our Psychotropic guidelines: https://bit.ly/493rNdg

28/10/2025

200 episodes of the Australian Prescriber Podcast! 👏 Catch up on today's episode as podcast host Justin Coleman chats with Dr Lee Fong about the latest updates to Therapeutic Guidelines: Oral and Dental.

🎧 Listen now: https://bit.ly/47oRqCK

27/10/2025

🚨 Update to CAP advice 🚨

For critically ill adults with high-severity community-acquired ( ), intravenous hydrocortisone is now recommended within 24 hours of diagnosis if they need high-flow oxygen or mechanical ventilation (invasive or noninvasive). It's also indicated if there's a concurrent condition, like a COPD exacerbation.

This is a significant step in managing high-severity CAP to improve patient outcomes. 💉🩺

Get the latest in the guidelines: https://bit.ly/4mpPD6l

23/10/2025

Our eight wonderful calculators have been re-implemented with a sleek interface and smarter functionality. You can now switch between calculators without losing data and easily convert between empirical and metric units.

Get calculating — your clinical decisions just got a whole lot sharper! https://bit.ly/4o13kK3